secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001193125-25-124047
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix shareholders approve reverse stock split ratio range 1:2 to 1:20
-------------------------------------------------------------------------

- Shareholders approved reverse stock split of common stock at ratio between 1-for-2 and 1-for-20, as determined by board.
- KPMG LLP ratified as independent auditor for FY 2025 with 124.9M votes for.
- ESPP amended: shares available increased by 1.45M; annual automatic increase cap raised to 3.0M.
- Lawrence T. Kennedy Jr. and Matthew Strobeck elected as Class II directors at annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312525124047/0001193125-25-124047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312525124047/d19624d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-124047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer